Rationale and Design of the Alpha-1 Biomarkers Consortium Study
Monica P Goldklang1, Cheryl Pirozzi2, Igor Barjaktarevic3
1Columbia University, New York, New York, United States.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|April 24, 2025
Summary
Alpha-1 antitrypsin deficiency (AATD) causes COPD with varied symptoms. This study uses CT scans and biomarkers to understand AATD
Area of Science:
- Pulmonary Medicine
- Genetics
- Biomarker Research
Background:
- Alpha-1 antitrypsin deficiency (AATD) is a primary genetic driver of chronic obstructive pulmonary disease (COPD).
- Significant variability in clinical presentation and disease progression exists among individuals with AATD, despite shared genetic variants.
- Understanding this heterogeneity is crucial for personalized management strategies.
Purpose of the Study:
- To investigate how computed tomography (CT) imaging and serum/airway biomarkers explain phenotypic variability in AATD.
- To identify factors associated with disease severity and progression in individuals with AATD.
- To establish a comprehensive longitudinal cohort for deep phenotyping of AATD.
Main Methods:
- A multi-center longitudinal study of 270 adult PiZZ AATD participants over 3 years.
- Data collection includes spirometry, patient-reported outcomes, biosampling (blood, sputum, nasal mucosa), and chest CT imaging.
- Genetic analysis (SERPINA1 sequencing) and iPSC generation from PBMCs will be performed.
Main Results:
- Deep characterization of the AATD cohort through cross-sectional and longitudinal imaging, physiological, and symptomatological data.
- Quantitative emphysema measures and novel airway remodeling metrics derived from CT imaging.
- A validation cohort in Ireland will independently enroll patients using identical procedures.
Conclusions:
- This study represents the first AATD cohort to integrate detailed quantitative emphysema measures and advanced imaging.
- The findings aim to elucidate the underlying mechanisms of AATD heterogeneity.
- Identification of key factors influencing disease severity and progression in AATD.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
66
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
66
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106


